Skip to content
10-Q

Quarterly Report

AV THERAPEUTICS, INC.

0001185185-14-001377

← back to feed
Filed
May 20, 2014 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2014 · May 13, 2014 81M sh
Capex Q1 2014 · Mar 31, 2014 $0
Capex Q1 2014 · Mar 31, 2014 $2.16K
Capex Q1 2014 · Mar 31, 2013 $0
Operating Cash Flow Q1 2014 · Mar 31, 2014 −$282.82K
Operating Cash Flow Q1 2014 · Mar 31, 2014 −$2.13M
Operating Cash Flow restated Q1 2014 · Mar 31, 2013 −$107.42K
Cash And Equivalents Q1 2014 · Mar 31, 2014 $293.43K
Cash And Equivalents Q1 2014 · Dec 31, 2013 $576.25K
Cash And Equivalents restated Q1 2014 · Mar 31, 2013 $65.01K
Cash And Equivalents restated Q1 2014 · Dec 31, 2012 $97.44K
Cash And Equivalents Q1 2014 · Jul 23, 2007 $0
Stockholders Equity Q1 2014 · Mar 31, 2014 −$982.29K
Stockholders Equity Q1 2014 · Dec 31, 2013 $34.17K
Current Liabilities Q1 2014 · Mar 31, 2014 $1.44M
Current Liabilities Q1 2014 · Dec 31, 2013 $750.76K
Current Assets Q1 2014 · Mar 31, 2014 $318.43K
Current Assets Q1 2014 · Dec 31, 2013 $636.25K
Total Assets Q1 2014 · Mar 31, 2014 $461.96K
Total Assets Q1 2014 · Dec 31, 2013 $784.93K
Sga Expense Q1 2014 · Mar 31, 2014 $51.91K
Sga Expense Q1 2014 · Mar 31, 2014 $165.25K
Sga Expense Q1 2014 · Mar 31, 2013 $10.77K
Rd Expense Q1 2014 · Mar 31, 2014 $115.25K
Rd Expense Q1 2014 · Mar 31, 2014 $2.37M
Rd Expense Q1 2014 · Mar 31, 2013 $27K
Net Income Q1 2014 · Mar 31, 2014 −$399.95K
Net Income Q1 2014 · Mar 31, 2014 −$5.14M
Net Income restated Q1 2014 · Mar 31, 2013 −$101.8K
Operating Income Q1 2014 · Mar 31, 2014 −$399.95K
Operating Income Q1 2014 · Mar 31, 2014 −$5.13M
Operating Income Q1 2014 · Mar 31, 2013 −$101.48K
Revenue Q1 2014 · Mar 31, 2014 $0
Revenue Q1 2014 · Mar 31, 2014 $0
Revenue Q1 2014 · Mar 31, 2013 $0